Evox Therapeutics
- Biotech or pharma, therapeutic R&D
At Evox Therapeutics, we focus on tackling genetically defined CNS disorders using exosome-based genome-editing therapeutics. Our lead programs address SCA2/ALS targeting ATXN2 and Huntington’s disease targeting MSH3
Address
OxfordOxfordshire
United Kingdom
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}